Millennium Management’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-128,756
| Closed | -$33K | – | 5479 |
|
2023
Q1 | $33K | Buy |
+128,756
| New | +$33K | ﹤0.01% | 4275 |
|
2022
Q4 | – | Sell |
-40,146
| Closed | -$10K | – | 6370 |
|
2022
Q3 | $10K | Buy |
+40,146
| New | +$10K | ﹤0.01% | 5039 |
|
2019
Q1 | – | Sell |
-981
| Closed | -$2K | – | 3871 |
|
2018
Q4 | $2K | Buy |
+981
| New | +$2K | ﹤0.01% | 3304 |
|
2017
Q4 | – | Sell |
-2,971
| Closed | -$25K | – | 3886 |
|
2017
Q3 | $25K | Sell |
2,971
-12,293
| -81% | -$103K | ﹤0.01% | 3178 |
|
2017
Q2 | $156K | Sell |
15,264
-10,290
| -40% | -$105K | ﹤0.01% | 3004 |
|
2017
Q1 | $295K | Sell |
25,554
-16,540
| -39% | -$191K | ﹤0.01% | 2822 |
|
2016
Q4 | $529K | Sell |
42,094
-7,519
| -15% | -$94.5K | ﹤0.01% | 2451 |
|
2016
Q3 | $908K | Sell |
49,613
-18,512
| -27% | -$339K | ﹤0.01% | 2113 |
|
2016
Q2 | $723K | Buy |
+68,125
| New | +$723K | ﹤0.01% | 2099 |
|
2016
Q1 | – | Sell |
-3,968
| Closed | -$106K | – | 3504 |
|
2015
Q4 | $106K | Buy |
+3,968
| New | +$106K | ﹤0.01% | 3021 |
|
2015
Q1 | – | Sell |
-1,360
| Closed | -$51K | – | 3524 |
|
2014
Q4 | $51K | Buy |
+1,360
| New | +$51K | ﹤0.01% | 3166 |
|
2014
Q3 | – | Sell |
-1,705
| Closed | -$50K | – | 3255 |
|
2014
Q2 | $50K | Buy |
+1,705
| New | +$50K | ﹤0.01% | 2738 |
|
2013
Q4 | – | Sell |
-1,361
| Closed | -$72K | – | 2927 |
|
2013
Q3 | $72K | Buy |
1,361
+396
| +41% | +$20.9K | ﹤0.01% | 2468 |
|
2013
Q2 | $52K | Buy |
+965
| New | +$52K | ﹤0.01% | 2435 |
|